e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Monitoring exacerbations of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical and functional assessment according to the exacerbating phenotype in COPD
V. Almadana, A. Valido, R. Tallón, J. Sánchez, C. Romero, T. Montemayor (Sevilla, Spain)
Source:
Annual Congress 2011 - Monitoring exacerbations of airway diseases
Session:
Monitoring exacerbations of airway diseases
Session type:
Thematic Poster Session
Number:
904
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Almadana, A. Valido, R. Tallón, J. Sánchez, C. Romero, T. Montemayor (Sevilla, Spain). Clinical and functional assessment according to the exacerbating phenotype in COPD. Eur Respir J 2011; 38: Suppl. 55, 904
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
Clinical and functional staging of COPD
Source: Annual Congress 2004 - Diagnosis and staging of COPD
Year: 2004
Clinical, functional and laboratory assessment of treatment efficacy in COPD patients
Source: International Congress 2014 – Predictors
Year: 2014
Clinical and functional characteristics of the natural course of COPD
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
The [bdquo]frequent exacerbator“ phenotype: Endothelial dysfunction and functional status
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Distribution of COPD phenotypes according to the Spanish COPD guidelines in clinical practice
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001
Determination of the existence of a correlation between lung function decline and changes in the COPD assessment test
Source: International Congress 2014 – Clinical presentations
Year: 2014
Correlation of clinical, laboratory and functional parameters in stable chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
The effects of standard therapy for COPD patients on FEV1 are associated with lower score of the Goddard classification
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Scales of assesment in COPD. Correlation with clinical and functional parameters
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Clinical features and functional parameters predict the probability of ACO in patients with asthma and COPD
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Effect of GERD on clinical severity and functional characteristics of lung function in asthma
Source: Annual Congress 2011 - Clinical parameters in airway diseases
Year: 2011
COPD severity analysis according to current evaluation criteria – National survey
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Role of functional assessment in asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Defining the clinical clusters of severe asthma within UBIOPRED
Source: International Congress 2015 – Fingerprinting severe asthma
Year: 2015
Asthma phenotyping: Correlation between inflammatory phenotype, clinical parameters and associated comorbidities
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
Clinical assessment and staging of COPD exacerbations
Source: International Congress 2014 – PG04 Update on COPD exacerbations
Year: 2014
Health status in the GOLD guidelines era. Assessing the new COPD severity staging criteria
Source: Eur Respir J 2002; 20: Suppl. 38, 251s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept